ABOUT US

ABOUT US

Accelerating drug development with synthetic biology and next-generation sequencing

 

We are a team of synthetic biologists, next-generation sequencing experts, and computational biologists focused on discovering better drugs faster.

 

Central to our vision is AlphaSeq, the leading technology for quantitative and multiplexed measurements of protein-protein interactions.

A-Alpha Bio was founded in 2017 as a spinout from the University of Washington's Institute for Protein Design and Center for Synthetic Biology. 

ABOUT A-ALPHA BIO

Management Team

BEST_linkedin.jpg

David co-invented AlphaSeq while working on his PhD in Bioengineering at the University of Washington with scientific advisors David Baker and Eric Klavins. He is an expert in developing and optimizing high-impact technologies by combining molecular biology, genetic engineering, and next-generation sequencing.

UNADJUSTEDNONRAW_thumb_1f80.jpg

Randolph received his PhD in Bioengineering from the University of Washington. Before UW, he was a Process Development Engineer at Illumina, where he was responsible for improving quality control efficiency and translating products into manufacturing. Since then, he has expanded his expertise into synthetic biology and computer science.

Ryan earned his PhD in Genome Sciences at the University of Washington before starting at Adaptive Biotechnologies. At Adaptive, he built and led the Antigen Map Project, in which Adaptive and Microsoft set out to jointly learn how to “read” the immune system for disease diagnosis. He is now using his expertise in sequencing, proteomics, and computational analysis to build and optimize A-Alpha Bio's data science pipeline.

Advisors

Dr. Eric Klavins, PhD

SCIENTIFIC ADVISOR  

Professor, UW Electrical Engineering

Director, UW Center for Synthetic Biology

Director, UW BIOFAB

Dr. David Baker, PhD

SCIENTIFIC ADVISOR

Professor, UW Biochemistry & HHMI

Director, UW Institute for Protein Design

Member, NAS & AAS

Dr. Lance Stewart, PhD, MBA

STRATEGIC & SCIENTIFIC ADVISOR  

CSOO, UW Institute for Protein Design

Co-founder, Beryllium Discovery & Northwest NeuroNeighborhood

Jade Brown, MBA

BUSINESS DEVELOPMENT ADVISOR 

Former CBO at Cell Therapeutics

Former VP of BD at Xencor
Former Director at Eli Lilly

Dr. Chris Gibson, PhD

STRATEGIC & SCIENTIFIC ADVISOR  

CEO and Co-Founder, Recursion Pharma